is it going to be a good day today, page-22

Joridigi I think you are discounting the Dendreon effect. I don't want to harp on but I've said this before:

1 - Dendreon has had a phenomenal run and has achieved what no other company has ever done before - get FDA approval for an immunotherapy based cancer vaccine.
2 - Prima has sister technology to their technology with similar early trial outcomes
3 - Small US investors have been unable to invest in Prima (and most probably don't know it exists - YET.)

It's the YET that makes all the difference. When they see it and suddenly realise that they can get in on the ground floor of what is potentially a 10-20 story building, that's what will make the difference.

________________________________
I have no knowledge beyond what's publicly available, but that doesn't stop me forming strong opinions! Which is all this post is. DYOR